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Abstract
Lumpectomy, also called breast-conserving surgery, has become the standard surgical treatment for early-stage breast
cancer. However, accurately locating the tumor during a lumpectomy, especially when the lesion is small and
nonpalpable, is a challenge. Such difficulty can lead to either incomplete tumor removal or prolonged surgical time,
which result in high re-operation rates (~25%) and increased surgical costs. Here, we report a fiber optoacoustic guide
(FOG) with augmented reality (AR) for sub-millimeter tumor localization and intuitive surgical guidance with minimal
interference. The FOG is preoperatively implanted in the tumor. Under external pulsed light excitation, the FOG
omnidirectionally broadcasts acoustic waves through the optoacoustic effect by a specially designed nano-composite
layer at its tip. By capturing the acoustic wave, three ultrasound sensors on the breast skin triangulate the FOG tip’s
position with 0.25-mm accuracy. An AR system with a tablet measures the coordinates of the ultrasound sensors and
transforms the FOG tip’s position into visual feedback with <1-mm accuracy, thus aiding surgeons in directly
visualizing the tumor location and performing fast and accurate tumor removal. We further show the use of a
head-mounted display to visualize the same information in the surgeons’ first-person view and achieve hands-free
guidance. Towards clinical application, a surgeon successfully deployed the FOG to excise a “pseudo tumor” in a
female human cadaver. With the high-accuracy tumor localization by FOG and the intuitive surgical guidance by AR,
the surgeon performed accurate and fast tumor removal, which will significantly reduce re-operation rates and
shorten the surgery time.
Introduction
In the United States, breast cancer ranks second as a
cause of cancer-related death in women1. Breast-
conserving surgery (BCS), or lumpectomy, is a standard
surgical treatment for early-stage breast cancer and is
favored for preservation of the breast, reduced morbidity,
and rapid recovery2–4. Although BCS is the preferred
surgical treatment for early-stage breast cancer, it can be
challenging to accurately identify the tumor site when the
tumor is small and nonpalpable5. This difficulty can lead
to inadequate clearance of the margins associated with
increased risk of local recurrence, and it requires a second
operation for adequate margins. The current re-operation
rate is approximately 25% on average, but some series
report rates as high as 37%6–10. Thus, surgical guidance
tools that can accurately locate the tumor and optimize
the resection of adequate margins in real time are needed.
Mammogram and magnetic resonance imaging are used
to diagnose and localize the breast tumor mass, but these
technologies are bulky in size and not accessible in the
operating room. The current gold standard of clinical
practice to help locate the tumor during the surgery is
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guide wire localization (GWL) prior to surgery, in which a
thin wire is inserted into the tumor mass under image
guidance with its terminal tip within the tumor or tumor
bed11. However, the location of the guide wire tip inside
the breast tissue is not visible to the surgeon and only
provides a rough estimation of the tumor location. Even
with the GWL method, the re-operation rate remains
high12,13. A newer method is seed implantation to
improve the localization of the tumor during the opera-
tion. By utilizing a handheld probe to detect a beacon that
is pre-implanted in the tumor mass, such as a radioactive/
radiofrequency seed14,15 or a radiofrequency identification
tag (RFID)16, the tumor location can be more accurately
identified. The radioactive/radiofrequency seed methods
can generally provide only the distance of the probe to the
beacon in terms of pseudo numbers without units, which
is a qualitative measure and is not accurate enough.
Although the RFID method can provide quantitative
tumor location information, it has a low accuracy of 15
mm. Light-guided lumpectomy, which employs an optical
fiber to deliver light to form a visible glowing ball in the
breast tissue, has also been developed. However, its
detection accuracy is limited and is dependent on the
depth of the implanted location (~9% of the depth)17.
Thus, all current technologies, clinical or preclinical, are
limited in localizing the tumor with sufficient accuracy.
Moreover, as the detection probe is a separate device from
the dissecting instrument, frequent switches between the
excision device and the detection probe occur during the
surgery, which interferes with the flow and prolongs the
surgical time. Furthermore, with continued improvement
in imaging technology, smaller lesions are being diag-
nosed, which increases the demand for high-precision
localization18. These limitations highlight an unmet need
for a precise surgical guidance tool that locates a small
tumor with high accuracy and minimal disruption of the
surgical flow.
To address this unmet surgical need, we developed a
fiber optoacoustic guide (FOG) that can locate a tumor
with sub-millimeter accuracy (see Materials and
methods). We further deployed an augmented reality
(AR) system to transfer the obtained tumor location into
an intuitive and accurate visual cue on a tablet or head-
mounted display (HMD) with 0.81-mm accuracy (Fig. 1a).
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Fig. 1 Using a fiber optoacoustic guide and an augmented reality (AR) system to locate the tumor and guide for fast and precise tumor
removal. a Principle of using a fiber optoacoustic guide (FOG) and an AR system to locate the FOG tip and provide the visual guidance on the AR
display. b Photograph of the compact integrated system on a cart. c Visualization of the FOG tip in the breast of a female human cadaver sample
(green sphere and marked by a red arrow)
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The FOG is a fiber-optic-based guide that is pre-
operatively implanted in the tumor. When connected to a
pulsed laser, the FOG emits omnidirectional waves at its
tip via the optoacoustic effect. Through acoustic trila-
teration (see Supplementary Materials) by an acoustic
radar with three ultrasound transducers, the tumor can be
located ðVF ;A!Þ with 0.25-mm accuracy. AR techniques
have recently been developed for intuitive surgical navi-
gation by merging the real-time operation with virtual
information segmented from preoperative images, which
then leads to improved surgical outcomes and minimal
interference to the surgical flow19–21. Here, we leveraged
the AR technology to track the acoustic radar VA;AR
! 
and thus transform the obtained tumor location into an
intuitive and accurate visual cue VF ;AR
! 
on a tablet or an
HMD (see Supplementary Materials). The visual guidance
requires no switch between the detection probe and the
excision device, and it can guide surgeons in performing
faster and more precise tumor removal. We built an AR
system in both tablet and HMD forms and achieved an
overall accuracy of 0.81 mm in the visualization of the
FOG tip.
We further integrated the entire system into a compact
transportable cart (see Supplementary Materials) for
clinical validation (Fig. 1b). Using a tablet-AR system, a
board-certified breast cancer surgeon successfully excised
a “pseudo tumor” from the breast of a female human
cadaver. Figure 1c shows a screenshot of the tablet display
with the visualization of the FOG tip (green dot, marked
by a red arrow) in the breast tissue of a female human
cadaver in the experiments. With the intuitive and accu-
rate visual guidance of the tumor location, our FOG, aided
with the AR system, provides a tool for surgeons to per-
form fast and precise tumor removal. This enhanced
method will have the potential to significantly reduce re-
operation rates and shorten surgery time, which translates
into a lower cost of care.
Materials and methods
Design of an FOG to locate the tumor with sub-millimeter
accuracy in BCS surgery
In BCS, a surgical beacon is preoperatively implanted to
mark the tumor location and guide the tumor removal in
the operating room. An ideal surgical beacon in the tumor
should be miniaturized (<mm diameter) to be implanted
in the tumor, and it should be detectable with high
accuracy over a wide range of angles and distances, while
having a low cost so that it can fit into current clinical
practice as a disposable device. Ultrasound, which can
carry spatial information with sub-millimeter accuracy
and propagates deeply into tissue, is a good candidate to
serve as a localization beacon in tumors for BCS. How-
ever, the currently available single-element ultrasound
transducers are either directional, that is, with limited
detectable angles, or omnidirectional, which is challen-
ging and expensive to manufacture because it consists of
miniaturized spherical piezoelectric transducers that can
broadcast acoustics omnidirectionally22,23. Moreover,
spherical transducers are bulky in size and have a center
frequency of several hundred kHz, which creates a
wavelength of several mm and does not allow sub-
millimeter localization accuracy. The fiber optoacoustic
emitter, which simply attaches a thin absorption layer on
the fiber tip to convert the pulsed light into acoustic
waves via the optoacoustic effect, has become an emer-
ging acoustic source because of its broadband acoustic
emission bandwidth and ease of fabrication24,25. However,
the current fiber optoacoustic emitters focus on gen-
erating directional acoustic emission for conventional
ultrasound imaging24, which is not a good fit in BCS for
the wide detectable angular range that is needed. Addi-
tionally, simply attaching the absorption layer at the fiber
tip is prone to breaking because of the tight confinement
of the high laser energy at the fiber tip.
Here, we developed a two-layer nano-composite struc-
ture at the fiber tip to generate acoustic waves in all
directions with sufficient intensity to penetrate deeply in
the tissue. The first layer comprises 100-nm zinc oxide
(ZnO) nanoparticles and epoxy (15% concentration by
weight), which diffuses the high-energy laser pulse into a
relative uniform angular distribution (Fig. S1). The second
layer is an absorption layer of graphite and epoxy (30%
concentration by weight), which completely absorbs the
diffused laser pulse (Fig. S2) and transforms it into omni-
directional acoustic waves. The nano-composite layer was
coated on the polished tip of one multimode optical fiber
(200 µm core diameter, FT200EMT, Thorlabs, Inc., New-
ton, NJ, USA) by two repetitive dipping steps (see Supple-
mentary Material). The finalized ball-shaped nano-
composite layer has an overall diameter of approximately
800 µm (Fig. 2a). This spherical geometry at close to a
millimeter size also facilitates the generation of acoustic
waves with frequencies of several MHz, which penetrate
deeply into the breast tissue and provide a long detectable
distance. Last, a hook sleeve is attached at the distal end to
prevent migration in the tissue. The finalized FOG is
threaded into an 18 G positioning needle used for the
current metal guide wire, minimizing the translational cost.
Measuring the acoustic emission profile and the frequency
of the FOG
A customized and compact passively Q-switched diode-
pumped solid state laser (1030 nm, 3 ns, 100 μJ, RPMC,
Fallon, MO, USA) was used as the excitation source for
the FOG. The laser is a fiber pigtailed laser, and it was
connected to the FOG through a homemade fiber jumper
(SMA-to-SC/PC, ~81% coupling efficiency). The laser
driver was adjusted to set the output power from the fiber
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jumper to be approximately 34 mW, which corresponds
to a pulse repetition rate of approximately 420 Hz. The
FOG tip was fixed in the water tank. One miniaturized
ultrasound transducer (XMS-310-B, Olympus, Waltham,
MA, USA) was mounted on a motorized rotation stage to
record the optoacoustic signals across different angles. An
additional three-dimensional (3D) translation stage was
used to adjust the FOG to make its tip well-centered. The
distance from the FOG tip to the transducer was 80mm.
The ultrasonic signal was first amplified by an ultrasonic
pre-amplifier (0.2–40MHz, 40 dB gain, Model 5678,
Olympus, Waltham, MA, USA) and then sent out to an
oscilloscope (DSO6014A, Agilent Technologies, Santa
Clara, CA, USA) to read out. The signal was averaged 16
times. By rotating the motorized stage, the peak-to-peak
values and the waveforms of the optoacoustic signal were
recorded at different angles, and the signal-to-noise ratios
(SNR) were calculated. All of the devices were synchro-
nized by the output from the active monitoring photo-
diode inside the laser.
Measuring the penetration depth of the acoustic signal
generated by the FOG
The inset in Fig. 2e shows the experimental schematic
used to investigate the penetration depth of the
optoacoustic signal that was generated. The FOG and the
same miniaturized ultrasound transducer were sub-
merged in a water tank and separated by approximately
13 cm. The miniaturized ultrasound transducer was
mounted on a three-axis translation stage. The same laser
was applied as the excitation source in this setup with the
same power. First, no chicken breast tissue was placed
between the ultrasound transducer and the FOG. We
aligned the ultrasound transducer with the FOG by
adjusting the three-axis translation stage to obtain the
optimal optoacoustic signal. Then, chicken breast tissues
of different thicknesses were placed between the ultra-
sound transducer and the FOG. The detected signal peak-
to-peak values were then recorded using a similar setup as
above, and the SNRs were calculated.
Characterizing the acoustic/optical tracking accuracy of
the FOG and AR system
Acoustic tracking accuracy of the FOG tip
The FOG was mounted on a 3D manual translation
stage. The acoustic radar, which has three identical min-
iaturized transducers (XMS-310-B, Olympus, Waltham,
MA, USA), is fixed on a post. Both the FOG and the
acoustic radar were submerged in a water tank. The three
transducers simultaneously acquired the acoustic signal
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Fig. 2 A fiber optoacoustic guide for tumor localization with sub-millimeter accuracy. a Photograph of the fiber optoacoustic guide (FOG), zinc
oxide nanoparticles, and epoxy forming the diffuser layer to diffuse the light, and the graphite and epoxy layer converts the light into an
optoacoustic signal. b Signal-to-noise ratio (SNR) of the generated optoacoustic signal from the FOG tip at different angles. The radius of the data
points marks its SNR (in dB): the further the data point lies, the higher the SNR is. c Representative optoacoustic signal waveform recorded 8 cm away
from the FOG tip in the forward direction. d Frequency spectrum of the representative optoacoustic signal waveform after normalization of the
detector’s response. e SNR of the generated optoacoustic signal after passing chicken breast tissue of different thicknesses: 0, 1, 2, 5, and 10 cm. The
inset shows the measurement setup
Lan et al. Light: Science & Applications  (2018) 7:2 Page 4 of 11
generated by the FOG tip. The signals were amplified by
three identical pre-amplifiers (40 dB gain) and then sent
to a host PC with an integrated data-acquisition card
(Oscar 16, 50MS/s, DynamicSignals, Lockport, IL, USA).
Through processing the delay of the recorded acoustic
signal to the excitation pulse, the distances of the FOG tip
to each transducer were obtained and then used to cal-
culate the 3D position of the FOG tip relative to the
acoustic radar via a trilateration algorithm. We shifted the
FOG with a given physical shift of 0.05 inches each time
using the 3D manual stage along its x, y, and z axes and
recorded the calculated 3D positions by the trilateration
algorithm. By comparing the calculated shifts against the
physical shifts by the stage along x, y, and z axes, the mean
errors of the trilateration for the x, y, and z movements
were characterized.
Optical tracking accuracy of the acoustic radar by the tablet-
AR system
The acoustic radar that tracks the FOG tip in tissue is
tracked through infrared (IR) markers by a stereo camera
in the tablet-AR system for later AR visual cue projection.
The IR marker group on the acoustic radar was fixed on a
3D manual translation stage. The stereo vision system was
placed ~40 cm away from the marker group, which was
approximately the same distance as the setup used in the
cadaver experiments. The stereo vision system was kept
static during the whole process. The marker group was
shifted at a fixed physical step of 0.05 inches each time on
the 3D manual stage along its x, y, and z axes. At each
step, the position of the rigid body’s pivot point, that is,
the center of all markers in the group, was streamed to the
hosting PC in real time and recorded. The marker group
movement was calculated from the optical tracking
results and compared against the physical shift of the
manual stage along the x, y, and z axes.
Projection accuracy of the FOG tip on the tablet-AR system
A square marker mount with a 4 × 4 checkerboard was
used to measure the projection error of the tablet-AR
system used in the cadaver experiments. The four markers
were mounted on the 3D-printed square board and
formed a rigid body that is coplanar and concentric with
the checkerboard. The center of the rigid body served as a
pseudo “FOG tip” position, where a sphere cue is ren-
dered. The tablet-AR system was placed at ~40, ~50, and
~60 cm from the checkerboard. At each distance, multiple
screenshots that contain both the rendered sphere cue
and the checkerboard were taken at various heights and
orientations. For each screenshot, the 2D position of the
visual cue rendered on the tablet display was obtained
from a robust circle detection method, while the 16
checkerboard corners were detected using the method
used in camera calibration (see Supplementary Material),
and their averaged center served as the ground truth of
the rendering. The absolute error between the rendered
pseudo “FOG tip” position and the ground truth provided
by the checkerboard was measured in pixels at each dis-
tance. With the physical distance and pixel distance
between the two corners farthest away on the checker-
board, the pixel-to-mm ratio on each screenshot was later
obtained to transfer the error from pixels to millimeters.
Female human cadaver sample
The female human cadaver sample was secured through
the surgery skill lab of the Department of Surgery, Indiana
University School of Medicine, as a surgery training
sample. The female human cadaver sample is a female of
66 years old and was deceased from a malignant brain
tumor. The experiment protocol was reviewed and
determined to be Internal Review Board exempt through
the determination form of exempt research request by the
human research protection program of Purdue University:
https://www.irb.purdue.edu/forms/. The entire experi-
ment was supervised by the surgery skill lab at the Indiana
University School of Medicine, and the whole cadaver
sample was collected and cremated according to standard
practice by The Cremation Center (1601 East New York
Street, Indianapolis, IN, USA) after the experiment.
Implantation of a breast biopsy clip to mark a “pseudo
tumor” for excision
Since a female human cadaver with a breast tumor is
difficult to obtain, we instead placed a standard breast
biopsy clip to represent the core of the “pseudo tumor,”
which was to be excised in our experiment. The breast
tumor biopsy clip is a small metal (stainless steel or tita-
nium) clip that is inserted into the breast to mark the
biopsy site, and it has been used as a guide to locate and
remove nonpalpable tumors26. With the imaging gui-
dance of a portable ultrasound imaging system (Lumify
ultrasound, C5-2 probe, Philips), a board-certified radi-
ologist identified a target position at approximately
10–20 mm depth in breast tissue with compression
applied. Then, the radiologist percutaneously deployed a
biopsy clip through a needle (UltraClip breast tissue
marker, Bard, Murray Hill, NJ, USA) into the position and
released the biopsy clip. After the release of the biopsy
clip, an ultrasound image sequence and snap shots were
recorded to confirm the placement of the biopsy clip in
the breast tissue.
Surgical procedure for removing a “pseudo tumor” from a
female human cadaver
Step 1: Implantation of the FOG
After the deployment of the biopsy clip, the ultrasound
probe was held in the same position, and the radiologist
percutaneously placed the two-part positioning needle
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with a trocar introducer (G19380, Kopans Breast Lesion
Localization Needle, Cook Medical, Bloomington, IN,
USA) into a position close to the implanted biopsy clip.
The two-part positioning needle was inserted into the
breast tissue along the direction from the medial to the
lateral side. Because the visualization of the needle
sometimes might not be clear in ultrasound imaging, the
radiologist gently pushed and pulled the needle to record
an ultrasound image sequence to confirm that the loca-
tion of the needle was close to the implanted biopsy clip.
The core needle was removed, and the introducer was left
inside the tissue. The same loading cannula that comes
with the introducer and had our optoacoustic guide wire
encapsulated was then fed into the introducer in the tis-
sue. Next, the radiologist advanced the FOG, released the
hook, and then removed the needle and the introducer.
Then, ultrasound images and sequences were taken to
confirm the placement of the FOG and its tip’s close
distance to the implanted biopsy clip. The guide wire
outside the breast tissue was later taped to the skin for the
subsequent visualization and excision experiments.
Step 2: Visualization of the FOG tip in the breast tissue with
the surgical navigation system
With the implantation of the biopsy clip and FOG, our
surgical navigation system was connected and turned on
to visualize the location of the FOG tip in the human
breast tissue. First, the proximal end of the implanted
FOG was connected to the compact pulsed laser. Second,
the acoustic radar was patched to the breast skin close to
the insertion site of the FOG by having its base attached
to the medial skin through a sticky pad. The supporting
arm of the acoustic radar was adjusted to ensure that the
acoustic radar was in firm contact with the breast skin.
Next, the tablet-based AR system mounted on the
articulating arm was moved to a position above the breast
to capture the entire operating scene and the acoustic
radar. Then, the host PC was turned on to receive and
process the acoustic signals. The tablet-AR system was
started later to receive the tracking information from the
host PC and render the visualization of the FOG tip on its
display. The tablet display was also streamed to a sec-
ondary monitor that is easier and friendlier for operators
to view. As a result, the FOG tip in the breast tissue was
visualized on the monitor. The tablet-AR system can be
moved to different positions to obtain a better view at the
operators’ preference.
Step 3: Excision of a “pseudo tumor” from a female human
cadaver with visualization guidance by the surgical naviga-
tion system
In addition to the visualization of the location of the
FOG tip in the breast tissue, our system also provided the
real-time distance from the tip of the scalpel to the FOG
tip to enable accurate tissue removal. In addition, an
auditory warning was given when the scalpel tip’s distance
to the FOG tip was less than the preset warning distance.
In the excision experiment on the cadaver, the warning
distance was set to 25mm. A board-certified breast sur-
geon successfully performed excision of the “pseudo
tumor” marked by the biopsy clip following the protocol
showed later in the results section.
Results and discussion
FOG omnidirectionally broadcasts the acoustic signal deep
in the tissue
Figure 2a shows that the FOG is a fiber-optics-based
guide with a nano-composite formed at its distal end,
which has an overall diameter of approximately 800 μm.
Under external laser excitation of ~0.1 mJ pulse energy, at
a 420-Hz repetition rate, the FOG successfully broadcasts
an acoustic signal with more than a 40-dB SNR (averaged
16 times, ~25-Hz final data refresh rate) over a 300°
angular range in water (Fig. 2b, see Supplementary
Material). This angular range result is limited by the
rotatable angles of our setup. A backward acoustic emis-
sion was observed in both water and human breast tissue,
which proves an omnidirectional acoustic emission of
FOG. Figure 2c shows a representative optoacoustic signal
measured in the experiment. Its radiofrequency spectrum
spans mainly the low-frequency range of 1–5MHz
(Fig. 2d) after normalization of the transducer response.
Since the frequency of an optoacoustic emitter relates to
its geometry27, the diameter of the composite sphere
being close to 1 mm could be one of the reasons for such a
low radiofrequency spectrum. Compared with the high-
frequency ultrasound wave, the generated optoacoustic
wave can penetrate much deeper through human tissue
due to its low-frequency nature. An SNR as high as 30 dB
after passing through the 10-cm-thick chicken breast
tissue was obtained in our experiments (Fig. 2e). This long
detection distance of the FOG fits well in the current BCS
operations, in which the guide wire is approximately
5–10 cm long. We note that laser diodes with a
longer pulse duration could be used as an alternative
excitation light source to lower the frequency of the
optoacoustic signal28, which also reduces the cost of the
system.
FOG locates the tumor with sub-millimeter accuracy
We fixed the acoustic radar with three transducers
(Fig. 3a.) to detect the acoustic signals to locate the FOG
tip and calculate the measured shifts. Compared with the
physical shifts applied, the mean error of the acoustic
tracking is 0.36, 0.32, and 0.10 mm for movement on the
x, y, and z axes, respectively, and the overall mean error is
0.25 mm (Fig. 3d). The above specifications demonstrate a
low-cost, compact, and high-intensity omnidirectional
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acoustic emitter that is suitable for use as an “acoustic
beacon” for tumor localization.
AR for real-time tumor localization with millimeter-level
accuracy
By placing the IR markers on the acoustic radar (Fig. 3b)
and using a similar setup, we translated the acoustic radar
with given physical shifts along the x, y, and z axes and
compared it with the calculated shifts by optical tracking
using a tablet-AR system (see Supplementary Material)
with a stereo IR camera (Fig. 3c). The mean error of the
depth sensing of the acoustic radar was measured to be
0.03, 0.05, and 0.14 mm for the x, y, and z movement,
respectively, and the overall mean error was 0.07 mm
(Fig. 3e).
Next, we used a customized checkboard with IR mar-
kers to compare the projected visual cue through our
calculation against the ground truth obtained from the
captured image of the checkboard. The error of projecting
the calculated position of the FOG tip on the tablet dis-
play was assessed. The tablet-AR system was placed at
approximately 40, 50, and 60 cm away from the check-
board in the experiments to measure the projection error,
which is approximately the distance of the AR system to
the operating scene in practice. It is observed that the
mean projection errors are 0.68, 0.75, and 1.03 mm at the
distances of 40, 50, and 60 cm, respectively, and the
overall mean projection is 0.81 mm (Fig. 3f).
In clinical practice, another important factor that would
contribute to the localization error is the sound speed
difference caused by the tissue inhomogeneity. Acoustic
waves travel faster in malignant tissue. The sound speeds
in malignant tissue (mostly palpable) and normal tissue
are ~1552 and ~1472mm/s, respectively, in the most
extreme case29. This sound speed difference is caused by
the change in the mechanical property. In our application,
we focus on the nonpalpable breast tumor, which has a
median size of approximately 13.8 mm and a sound speed
closer to the normal tissue than the palpable tumors30.
Thus, the localization error caused by tissue inhomo-
geneity is estimated to be <0.4 mm in the most extreme
case described. This tissue inhomogeneity error is still
within the sub-millimeter level, similar to in the acoustic,
optical tracking, and projection errors of our system.
By characterizing the error of the acoustic localization,
optical tracking, projection, and tissue inhomogeneity, it
is found that the projection error is the largest error, but
all of the four errors are at a sub-millimeter level, which
suggests an overall millimeter-level accuracy of our sys-
tem. Therefore, our FOG together with the tablet-AR
system demonstrates an intuitive visual guidance of the
tumor location with a millimeter-level accuracy, which
fulfills the need for accurate tumor localization.
Visualization of the FOG tip in breast tissue in a female
human cadaver
With the implantation of the FOG in the left breast of a
female human cadaver, the tablet-AR system was set up to
visualize the FOG tip in the breast. Before turning on the
system, through the guide wire outside the breast (marked
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by the black arrow in Fig. 4a), it was difficult to estimate
the location of the FOG tip in the breast. After turning on
the system, the FOG tip’s location in the breast was clearly
visualized on the tablet display, which is represented by
green dots and marked by red arrows in Fig. 4b–d. The
FOG tip was always visualized (Fig. 4b–d), even when the
tablet was placed at different heights and angles to the
breast (Fig. 4f–h). Additionally, by attaching another
group of IR markers to the surgical scalpel, the real-time
distance of the scalpel tip to the guide wire tip was
obtained as additional guidance (see Supplementary
Material). Through reading this real-time distance on the
bottom left of the tablet display over Fig. 4b–d, the
visualization was proved to be quite stable. The distances
were calculated to be 276.67 mm on average, with a
maximum deviation of 0.61 mm, which is approximately
the same level of overall tracking accuracy of our system.
The stable visualization of the FOG tip can also be seen
from the Movie S1, in which the visualization of the FOG
tip was recorded when the tablet was in motion, and a 50-
time signal average was used in the cadaver experiments.
To further reduce the surgical interference, we also
explored the use of an HMD-AR system (Hololens,
Microsoft, Syracuse, NY, USA) to visualize the FOG tip in
the breast tissue in the first-person view of the operator.
As a proof-of-concept, we used the RGB camera built in
the Hololens to sense the acoustic radar. Thus, instead of
using passive IR markers, an image target was placed on
the acoustic radar for the RGB camera tracking (Fig. 5a)
(see Supplementary Material). In view of the operation
captured by the Hololens camera, it was difficult to esti-
mate the location of the FOG tip in the breast tissue
before turning on the system (Fig. 5a). After turning on
the system, the FOG tip’s location in the breast was clearly
visualized on the Hololens display, which is represented
by green spheres and marked by red arrows in Fig. 5b–d.
When viewing the operating scene over different dis-
tances and angles (Fig. 5f–h) to the breast, the visualiza-
tion of the FOG tip in the breast was stable (Fig. 5b–d).
This is clear in the recorded video when the operator
moved with the Hololens (Movie S2). Thus, using an
HMD-AR system, visual guidance in the first-person-view
of the operator can be provided, which has the potential
to achieve hands-free surgical guidance with the least
interference to the flow.
Compared to a conventional AR surgical guidance sys-
tem, our FOG-AR system locates the target lesion in soft
tissue with higher accuracy and therefore offers more
precise surgical guidance because a conventional AR
system utilizes the target lesion information segmented
FOG
wire
a
e f g h
b c d
Scalpel
PosTip:
(0.0000, 0.0000, 0.0000)
Dist (mm):
276.34
Dist (mm):
276.40
Dist (mm):
277.28
Fig. 4 Visualization of the FOG tip in the breast tissue of a female human cadaver sample using the tablet-AR system at different view
angles and distances. a It is difficult to estimate the location of the FOG tip in the breast from the guide wire outside the breast (black arrow) before
turning on our system. b–d Clear visualizations of the FOG tip in the tissue on the AR display at different view angles and distances. The real-time
distance of the static scalpel tip to the FOG tip is displayed on the bottom left of the AR display. e–h The positions of the tablet-AR system relative to
the breast tissue in a–d, respectively
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from static preoperative images, and soft tissue is subject
to a large amount of movement and deformation during
surgery. In contrast, our FOG implanted in the tumor
moves along with the tumor when tissue movement and
deformation occur. The FOG dynamically locates the
target lesion during the surgery, and the AR system
converts it into an intuitive visual guidance in real time.
Therefore, our technology has higher resistance to the
tissue movement and deformation and thus locates the
target lesion in soft tissue with higher accuracy.
Excision of a “pseudo tumor” in a human cadaver guided
by FOG and tablet-AR
To validate the efficacy of the FOG and the tablet-AR
system, we performed an excision experiment of a
“pseudo tumor” marked by a pre-implanted biopsy clip in
the breast of a female human cadaver. In the experiments,
the FOG was placed close to the biopsy clip as the guide
for visualization of the tumor location by a board-certified
radiologist. Both the biopsy clip and the FOG were
implanted in the breast by a board-certified radiologist
with specialty training in breast imaging through a stan-
dard clinical practice method (Movie S3). The locations of
the biopsy clip and the FOG tip were confirmed to be at a
close distance in the ultrasound image (Fig. 6a) and
Movie S3. After the implantation, the tablet-AR system
was set up (Fig. 6b). Figure 6c shows the visualization of
the FOG tip on the tablet display in the experiment.
By mounting IR markers on the off-shelf scalpel used and
tracking the scalpel with those markers, the real-time
distance from the scalpel tip to the FOG tip was
obtained and displayed on the tablet display as additional
guidance.
By following the excision protocol (Fig. 6d), a board-
certified breast cancer surgeon performed the excision
experiment. After turning on the system and visualizing
the FOG tip in the breast, the surgeon first made the
incision on the skin close to the FOG tip. Then, the
surgeon excised the pseudo tumor with a scalpel. An
auditory alert was provided to the surgeon when the real-
time distance of the scalpel tip to the FOG tip was less
than the preset warning distance dw. The warning dis-
tance was set to be 25 mm in the experiment. In contrast
to methods using a handheld probe to locate the tumor,
our visualization guidance is more intuitive, and the
auditory feedback on the scalpel’s distance to the tumor
requires no switch between the excision device and the
detection probe, which greatly reduces the interference to
the surgical flow. Figure 6e shows the image of the sur-
geon using the scalpel and our system to excise, and the
complete excision process was recorded in Movie S4.
After dissecting all of the margins and cutting the guide
wire, the “pseudo tumor” was excised (Fig. 6f). Due to the
low contrast of the low-frequency portable ultrasound
imaging probe, we transected the excised tissue to con-
firm that both the FOG tip and the biopsy clip (Fig. 6g)
were included in the resection.
Conclusions
We developed a compact, mobile surgical navigation
system that utilizes a FOG to locate a tumor with
0.25-mm accuracy and an AR system display on a tablet to
Acoustic
radar
FOG wire
a b c d
e f g h
Fig. 5 Visualization of the FOG tip in the breast tissue of a female human cadaver sample using the head-mounted display AR system
(Hololens) over different view angles and distances. a It is difficult to estimate the location of the FOG tip in the breast from the guide wire
outside the breast (white arrow) before turning on the system. An image target is used instead of IR markers to track the acoustic radar. b–d Clear
visualizations of the FOG tip in the tissue on the stereo view from the head-mounted display (HMD) on the operator’s head when the operator views
the operating scene at different view angles and distances. e–h The positions of the HMD-AR system relative to the breast tissue in a–d, respectively
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visualize the tumor location with a 0.81-mm mean error
at a 25-Hz data refresh rate. The FOG dynamically locates
the target lesion during surgery, and the AR systems
convert it into an intuitive visual guidance in real time.
Therefore, our system has higher resistance to the tissue
movement and deformation and thus locates the target
lesion in soft tissue with higher accuracy. To improve the
excision efficiency and accuracy, our system can be fur-
ther applied for accurate target lesion localization and
removal in other soft tissues, such as kidney and liver,
which demand precise lesion removal and maximum
normal tissue preservation31,32. Towards clinical transla-
tion, a surgeon successfully deployed the FOG to excise a
“pseudo tumor” in a female human cadaver. By offering
sub-millimeter tumor localization and intuitive real-time
surgical guidance, our system can help to achieve precise
and fast tumor removal, reduce the high re-operation
rates and therefore reduce the cost of care. Moreover, the
real-time localization of the target lesion by our system
with a sub-millimeter accuracy could be exploited to
achieve precise supervised/semi-automatic or automatic
surgeries, such as laparoscopic surgeries, in soft tissue
when combined with surgery robots33.
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